{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:32:05Z","timestamp":1791873125160,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005790","name":"Thammasat University","doi-asserted-by":"publisher","award":["MURA2021\/447"],"award-info":[{"award-number":["MURA2021\/447"]}],"id":[{"id":"10.13039\/501100005790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005790","name":"Thammasat University","doi-asserted-by":"publisher","award":["287\/2021"],"award-info":[{"award-number":["287\/2021"]}],"id":[{"id":"10.13039\/501100005790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005790","name":"Thammasat University","doi-asserted-by":"publisher","award":["MURA2021\/264"],"award-info":[{"award-number":["MURA2021\/264"]}],"id":[{"id":"10.13039\/501100005790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005790","name":"Thammasat University","doi-asserted-by":"publisher","award":["MURA2020\/568"],"award-info":[{"award-number":["MURA2020\/568"]}],"id":[{"id":"10.13039\/501100005790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["N35A650052"],"award-info":[{"award-number":["N35A650052"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["\\u0E01\\u0E1A\\u0E172)\/332\/2564"],"award-info":[{"award-number":["\\u0E01\\u0E1A\\u0E172)\/332\/2564"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["N35A650417"],"award-info":[{"award-number":["N35A650417"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.clim.2025.110507","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T19:11:21Z","timestamp":1745867481000},"page":"110507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Persistent IP-10\/CXCL10 dysregulation following mild Omicron breakthrough infection: Immune network signatures across COVID-19 waves and implications for mRNA vaccine outcomes"],"prefix":"10.1016","volume":"278","author":[{"given":"Vimvara","family":"Vacharathit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutita","family":"Pluempreecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwimon","family":"Manopwisedjaroen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanya","family":"Srisaowakarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirawat","family":"Srichatrapimuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paskorn","family":"Sritipsukho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naiyana","family":"Sritipsukho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunee","family":"Thitithanyanont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clim.2025.110507_bb0005","first-page":"162","article-title":"SARS-CoV-2 variant biology: immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.clim.2025.110507_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2381","article-title":"Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: implications for immune escape and transmission","volume":"32","author":"Shrestha","year":"2022","journal-title":"Rev. Med. Virol."},{"issue":"10323","key":"10.1016\/j.clim.2025.110507_bb0015","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(22)00056-3","article-title":"Omicron severity: milder but not mild","volume":"399","author":"Nealon","year":"2022","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.clim.2025.110507_bb0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-012328","article-title":"Severity and outcomes of omicron variant of SARS-CoV-2 compared to Delta variant and severity of omicron sublineages: a systematic review and metanalysis","volume":"8","author":"Relan","year":"2023","journal-title":"BMJ Glob Health"},{"issue":"7","key":"10.1016\/j.clim.2025.110507_bb0025","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/all.14364","article-title":"Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19","volume":"75","author":"Azkur","year":"2020","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.clim.2025.110507_bb0030","doi-asserted-by":"crossref","first-page":"22152","DOI":"10.1038\/s41598-023-49098-x","article-title":"Epidemiological and clinical features of SARS-CoV-2 omicron variant infection in Quanzhou, Fujian province: a retrospective study","volume":"13","author":"Zhang","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.clim.2025.110507_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28224","article-title":"Clinical characteristics of 1139 mild cases of the SARS-CoV-2 omicron variant infected patients in Shanghai","volume":"95","author":"Wang","year":"2023","journal-title":"J. Med. Virol."},{"issue":"7","key":"10.1016\/j.clim.2025.110507_bb0040","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/infdis\/jiab005","article-title":"Early differences in cytokine production by severity of coronavirus disease 2019","volume":"223","author":"Tjan","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2025.110507_bb0045","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ijid.2021.09.021","article-title":"SARS-CoV-2 neutralizing antibodies decline over one year and patients with severe COVID-19 pneumonia display a unique cytokine profile","volume":"112","author":"Vacharathit","year":"2021","journal-title":"Int. J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.clim.2025.110507_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073673","article-title":"What is currently known about the role of CXCL10 in SARS-CoV-2 infection?","volume":"23","author":"Gudowska-Sawczuk","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2025.110507_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.156111","article-title":"Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia","volume":"162","author":"Samaras","year":"2023","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.clim.2025.110507_bb0060","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s10020-020-00230-x","article-title":"IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19","volume":"26","author":"Chen","year":"2020","journal-title":"Mol. Med."},{"key":"10.1016\/j.clim.2025.110507_bb0065","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.4049\/jimmunol.168.7.3195","article-title":"IFN-\u03b3-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and Trafficking1","volume":"168","author":"Dufour","year":"2002","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2025.110507_bb0070","first-page":"121","article-title":"CXCL10\/IP-10 in infectious diseases pathogenesis and potential therapeutic implications","volume":"22","author":"Liu","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.clim.2025.110507_bb0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cyto.2018.11.018","article-title":"IP-10 is highly involved in HIV infection","volume":"115","author":"Lei","year":"2019","journal-title":"Cytokine"},{"issue":"09","key":"10.1016\/j.clim.2025.110507_bb0080","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1055\/s-0034-1382053","article-title":"IP-10 in autoimmune thyroiditis","volume":"46","author":"Ruffilli","year":"2014","journal-title":"Horm. Metab. Res."},{"issue":"19","key":"10.1016\/j.clim.2025.110507_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194954","article-title":"Interferon-inducible protein 10 and disease activity in systemic lupus erythematosus and lupus nephritis: a systematic review and Meta-analysis","volume":"20","author":"Puapatanakul","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.clim.2025.110507_bb0090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S1473-3099(22)00640-5","article-title":"Hybrid immunity and strategies for COVID-19 vaccination","volume":"23","author":"Hui","year":"2023","journal-title":"Lancet Infect. Dis."},{"issue":"9","key":"10.1016\/j.clim.2025.110507_bb0095","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1038\/s41591-023-02521-2","article-title":"Postacute sequelae of COVID-19 at 2 years","volume":"29","author":"Bowe","year":"2023","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.clim.2025.110507_bb0100","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1001\/jama.2024.24184","article-title":"2024 update of the RECOVER-adult long COVID research index","volume":"333","author":"Geng","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.clim.2025.110507_bb0105","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1038\/s41467-023-43661-w","article-title":"True prevalence of long-COVID in a nationwide, population cohort study","volume":"14","author":"Hastie","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2025.110507_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajmo.2023.100033","article-title":"Epidemiological and clinical perspectives of long COVID syndrome","volume":"9","author":"Huerne","year":"2023","journal-title":"Am. J. Med. Open"},{"issue":"9","key":"10.1016\/j.clim.2025.110507_bb0115","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/01410768211032850","article-title":"Symptoms, complications and management of long COVID: a review","volume":"114","author":"Aiyegbusi","year":"2021","journal-title":"J. R. Soc. Med."},{"issue":"4","key":"10.1016\/j.clim.2025.110507_bb0120","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41590-024-01795-z","article-title":"Immune dysregulation in long COVID","volume":"25","author":"Ceglarek","year":"2024","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2025.110507_bb0125","doi-asserted-by":"crossref","first-page":"23441","DOI":"10.1038\/s41598-024-75233-3","article-title":"Long COVID at 3 and 6 months after covid-19 infection in Thailand","volume":"14","author":"Rutjanawech","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2025.110507_bb0130","series-title":"Clinical Management of COVID-19: Interim Guidance","author":"World Health O","year":"2020"},{"issue":"1","key":"10.1016\/j.clim.2025.110507_bb0135","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1038\/s41598-021-83139-7","article-title":"Network analysis of the immune state of mice","volume":"11","author":"Fonseca dos Reis","year":"2021","journal-title":"Sci. Rep."},{"issue":"23","key":"10.1016\/j.clim.2025.110507_bb0140","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1093\/bioinformatics\/bty407","article-title":"Nextstrain: real-time tracking of pathogen evolution","volume":"34","author":"Hadfield","year":"2018","journal-title":"Bioinformatics"},{"issue":"12","key":"10.1016\/j.clim.2025.110507_bb0145","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1084\/jem.187.12.2009","article-title":"Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3","volume":"187","author":"Cole","year":"1998","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.clim.2025.110507_bb0150","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.187.6.875","article-title":"Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes","volume":"187","author":"Sallusto","year":"1998","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.clim.2025.110507_bb0155","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1084\/jem.189.11.1765","article-title":"Acquisition of selectin binding and peripheral homing properties by CD4(+) and CD8(+) T cells","volume":"189","author":"Xie","year":"1999","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.clim.2025.110507_bb0160","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1084\/jem.184.3.963","article-title":"Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes","volume":"184","author":"Loetscher","year":"1996","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.clim.2025.110507_bb0165","first-page":"121","article-title":"CXCL10\/IP-10 in infectious diseases pathogenesis and potential therapeutic implications","volume":"22","author":"Liu","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.clim.2025.110507_bb0170","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1038\/s41467-020-19057-5","article-title":"SARS-CoV-2 viral load is associated with increased disease severity and mortality","volume":"11","author":"Fajnzylber","year":"2020","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.clim.2025.110507_bb0175","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1189\/jlb.3A0414-232RR","article-title":"High IP-10 levels decrease T cell function in HIV-1-infected individuals on ART","volume":"96","author":"Ramirez","year":"2014","journal-title":"J. Leukoc. Biol."},{"issue":"8","key":"10.1016\/j.clim.2025.110507_bb0180","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1177\/135965350801300815","article-title":"IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection","volume":"13","author":"Reiberger","year":"2008","journal-title":"Antivir. Ther."},{"issue":"3","key":"10.1016\/j.clim.2025.110507_bb0185","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","article-title":"Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases","volume":"13","author":"Antonelli","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"6","key":"10.1016\/j.clim.2025.110507_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109504","article-title":"Systemic IL-15, IFN-\u03b3, and IP-10\/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients","volume":"36","author":"Bergamaschi","year":"2021","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.clim.2025.110507_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0301330","article-title":"Infection kinetics, syncytia formation, and inflammatory biomarkers as predictive indicators for the pathogenicity of SARS-CoV-2 variants of concern in Calu-3 cells","volume":"19","author":"Purwono","year":"2024","journal-title":"PloS One"},{"key":"10.1016\/j.clim.2025.110507_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104552","article-title":"Cellular and molecular biomarkers of long COVID: a scoping review","volume":"91","author":"Esp\u00edn","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.clim.2025.110507_bb0205","series-title":"Encyclopedia of Virology","first-page":"428","article-title":"Human coronavirus-229E, -OC43, -NL63, and -HKU1 (Coronaviridae)","author":"Liu","year":"2021"},{"issue":"10","key":"10.1016\/j.clim.2025.110507_bb0210","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S1473-3099(21)00568-5","article-title":"CoronaVac induces lower neutralising activity against variants of concern than natural infection","volume":"21","author":"Vacharathit","year":"2021","journal-title":"Lancet Infect. Dis."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661625000828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661625000828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:37:51Z","timestamp":1762547871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661625000828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":42,"alternative-id":["S1521661625000828"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2025.110507","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent IP-10\/CXCL10 dysregulation following mild Omicron breakthrough infection: Immune network signatures across COVID-19 waves and implications for mRNA vaccine outcomes","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2025.110507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110507"}}